/

LMAT

LeMaitre Vascular, Inc.Open

82.57−0.34 −0.41%USD

NasdaqGM · as of Oct 13, 10:16 ET · 15m delay

Open

83.64

Prev close

82.91

Day range

81.2983.85

52-week range

78.22118.01

Volume

27.16K0.08×

Mkt cap

1.89B

P/E ttm

28.97

Fwd P/E

25.98

EPS ttm

2.85

Div yield

1.21%

Earnings

Nov 4, 2026

From 52w high

−30.03%

Price Chart

Yahoo Finance · delayed

LMATOct 13, 2026O 83.64H 83.85L 81.29C 82.57−0.34 (−0.41%)Vol 27.16K

SMA 5081.32
SMA 20094.47

1Y change −4.04% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

LMAT LeMaitre Vascular, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +4.45%
1 month: +2.46%
3 months: −15.62%
6 months: −29.66%
Year to date: +1.81%
1 year: −3.21%

Valuation & ownership

Market cap: 1.89B
Enterprise value: 1.71B
P/E (ttm): 28.97
Forward P/E: 25.98
PEG ratio: 2.13
Price / book: 4.49
Price / sales (ttm): 7.20
EV / EBITDA: 20.60
EPS (ttm): 2.85
EPS (forward): 3.18
Beta (5y monthly): 0.47
Dividend yield: 1.21%
Payout ratio: 31.58%
Shares outstanding: 22.87M
Float: 21.30M
Short % of float: 9.56%
Short ratio (days): 6.58
Held by insiders: 6.52%
Held by institutions: 103.94%
Avg volume (3m): 324.88K
50-day average: 81.74
200-day average: 94.48
52-week change: −3.21%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 54.7
vs 50-day SMA: +1.54%
vs 200-day SMA: −12.60%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.71%
Realised vol (20d, ann.): 23.7%
From 52-week high: −30.03%
From 52-week low: +5.56%

ANR

Analyst Consensus

7 analysts

Consensus

Buy

2.25 on a 1 (strong buy) – 5 (sell) scale

Mean target

107.00

+29.59% implied

Low 81.00Median 100.00High 132.00

Recommendation trend

Now4 / 4 / 0
1m ago4 / 4 / 0

DES

About LeMaitre Vascular, Inc.

Yahoo Finance profile

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 646

SEAS

Seasonality · LMAT

2007–2026 · monthly returns

Strongest month Jul +6.20%Weakest month Oct −3.59%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	4.8	27.3	0.9	0.5	-13.8	1.4	5.6	-20.8	2.9	-0.0			+1.8%
2025	5.2	-5.2	-8.7	8.2	-9.4	1.0	-2.2	17.4	-8.2	-1.0	-4.2	-2.2	−12.0%
2024	2.3	20.6	-5.2	-2.4	21.7	4.3	5.6	3.9	2.9	-4.8	21.0	-13.9	+62.3%
2023	2.5	6.2	2.7	4.9	16.4	7.1	-6.0	-8.6	-5.8	-10.8	8.5	7.7	+23.3%
2022	-15.8	12.2	-2.1	-7.0	5.8	-0.4	10.5	-1.9	2.6	-14.4	7.9	-1.8	−8.4%
2021	18.7	6.9	-5.1	7.6	-2.4	19.2	-10.8	4.0	-6.2	-2.0	-10.0	7.4	+24.0%
2020	0.1	-20.8	-12.6	14.3	-5.6	-1.8	11.1	10.1	0.8	-0.2	21.3	2.8	+12.7%
2019	0.8	25.5	3.6	-6.8	-10.6	8.4	18.3	-4.3	8.0	1.2	2.8	1.1	+52.1%
2018	9.3	-0.1	4.2	-13.2	8.4	-1.8	7.5	4.2	3.3	-31.1	4.5	-15.2	−25.8%
2017	-10.4	-2.5	11.2	20.8	2.7	2.2	15.5	0.9	2.8	-14.5	2.9	-3.3	+25.7%
2016	-15.4	0.9	5.4	6.8	-15.7	2.1	20.5	6.9	7.9	5.5	8.3	11.8	+46.9%
2015	3.9	-4.2	10.0	8.1	11.9	18.9	18.1	-7.2	-7.8	9.3	15.8	11.8	+125.5%
2014	-0.5	2.8	-1.5	1.7	-8.3	9.8	-1.9	-10.0	-5.8	6.4	0.4	4.1	−4.5%
2013	10.6	-3.9	1.6	-2.3	8.3	-0.3	4.4	1.6	-3.5	20.0	2.5	-2.8	+39.5%
2012	-2.0	-3.4	5.2	-8.3	3.1	7.7	5.0	-3.7	5.8	-8.9	10.3	-11.0	−3.0%
2011	4.7	-5.5	1.6	0.4	3.2	0.1	-6.4	6.5	-11.8	-7.1	-4.8	7.6	−12.6%
2010	-7.0	4.1	-7.0	9.8	10.9	2.2	7.9	18.4	-1.4	-7.8	2.8	1.3	+35.4%
2009	-8.2	8.0	10.5	1.2	6.6	15.8	9.2	-0.9	19.6	4.4	13.6	3.1	+116.5%
2008	-11.1	-13.8	-31.6	28.6	-23.4	-5.9	11.3	1.5	-5.6	-11.2	-20.0	1.3	−62.7%
2007	5.3	5.1	-3.9	-9.4	5.5	-1.6	0.2	13.1	10.9	-1.3	-4.4	-12.8	+3.3%

INSD

Insider Activity · LMAT

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

38.2K shares

Sells, 6 months

55.5K shares

Net shares

−17.2K

Net change in insider shares

−1.10%

Date	Insider	Transaction	Shares	Value
Aug 31, 2026	Roush John AdamDirector	Conversion of Exercise of derivative security at price 48.60 per share.	3.4K	$167.38K
Jun 3, 2026	Lemaitre George WChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	12K	—
Jun 3, 2026	Lemaitre George WChief Executive Officer	Stock Gift at price 0.00 per share.	12K	—
May 7, 2026	Lemaitre George WChief Executive Officer	Sale at price 107.64 - 108.69 per share.	46.5K	$5.03M
May 6, 2026	Ross Bridget A.Director	Sale at price 111.10 per share.	5K	$560.37K
May 6, 2026	Ross Bridget A.Director	Conversion of Exercise of derivative security at price 47.19 - 48.60 per share.	5K	$242.88K
May 6, 2026	Jasinski Lawrence JDirector	Sale at price 110.00 per share.	3.9K	$433.73K
May 6, 2026	Jasinski Lawrence JDirector	Conversion of Exercise of derivative security at price 47.19 - 101.12 per share.	2.9K	$188.41K
Apr 21, 2026	Pellegrino Joseph P JrDirector	Conversion of Exercise of derivative security at price 35.48 per share.	2.9K	$104.35K
Mar 10, 2026	Kamke Trent GOfficer	Sale at price 108.50 per share.	2.6K	$284.81K
Mar 10, 2026	Kamke Trent GOfficer	Conversion of Exercise of derivative security at price 35.48 per share.	2.6K	$93.14K
Mar 10, 2026	Roberts David BrianPresident	Sale at price 107.68 per share.	3.3K	$356.59K
Mar 9, 2026	Leblanc Dorian Paul CpaChief Financial Officer	—	2	—
Mar 1, 2026	Lemaitre George WChief Executive Officer	Stock Gift at price 0.00 per share.	5K	—
Mar 1, 2026	Lemaitre George WChief Executive Officer	Sale at price 106.76 - 107.81 per share.	205.9K	$22.04M
Feb 26, 2026	Kamke Trent GOfficer	Sale at price 110.29 per share.	1K	$115.14K
Feb 26, 2026	Roberts David BrianPresident	Sale at price 106.80 per share.	8.5K	$903.96K
Feb 25, 2026	Roush John AdamDirector	Stock Award(Grant) at price 0.00 per share.	476	—
Feb 25, 2026	Roush John AdamDirector	—	1	—
Feb 25, 2026	Kamke Trent GOfficer	Stock Award(Grant) at price 0.00 per share.	1.1K	—

13F

Investors Holding LMAT

latest 13F filings of 29 followed managers

Investors holding LMAT
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$16.3M	0.02%	169.50K	+22%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

LMAT

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

LMAT

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About LeMaitre Vascular, Inc.

Seasonality · LMAT

Insider Activity · LMAT

Congress Trades · LMAT

Investors Holding LMAT

Investors Holding LMAT

Congress Trades · LMAT

Insider Activity · LMAT

Seasonality · LMAT

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About LeMaitre Vascular, Inc.

Financial Snapshot

Earnings & Dividends

News